209 related articles for article (PubMed ID: 26398832)
21. Polymorphism of DC-SIGN (CD209) promoter in association with clinical symptoms of dengue fever.
Oliveira LF; Lima CP; Azevedo Rdo S; Mendonça DS; Rodrigues SG; Carvalho VL; Pinto EV; Maia AL; Maia MH; Vasconcelos JM; Silva AL; Nunes MR; Sena L; Vasconcelos PF; Santos EJ
Viral Immunol; 2014 Jun; 27(5):245-9. PubMed ID: 24797508
[TBL] [Abstract][Full Text] [Related]
22. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.
He J; Feng D; de Vlas SJ; Wang H; Fontanet A; Zhang P; Plancoulaine S; Tang F; Zhan L; Yang H; Wang T; Richardus JH; Habbema JD; Cao W
BMC Infect Dis; 2006 Jul; 6():106. PubMed ID: 16824203
[TBL] [Abstract][Full Text] [Related]
23. Association between CD209 -336A/G and -871A/G polymorphisms and susceptibility of tuberculosis: a meta-analysis.
Chang K; Deng S; Lu W; Wang F; Jia S; Li F; Yu L; Chen M
PLoS One; 2012; 7(7):e41519. PubMed ID: 22911807
[TBL] [Abstract][Full Text] [Related]
24. 2'-5'-Oligoadenylate synthetase 1 polymorphisms are associated with tuberculosis: a case-control study.
Wu S; Wang Y; Chen G; Zhang M; Wang M; He JQ
BMC Pulm Med; 2018 Nov; 18(1):180. PubMed ID: 30497421
[TBL] [Abstract][Full Text] [Related]
25. The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus.
Bréhin AC; Casadémont I; Frenkiel MP; Julier C; Sakuntabhai A; Desprès P
Virology; 2009 Feb; 384(1):216-22. PubMed ID: 19056102
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the relationship between single nucleotide polymorphism of the CD209, IL-10, IL-28 and CCR5 D32 genes with the human predisposition to developing tick-borne encephalitis.
Czupryna P; Parczewski M; Grygorczuk S; Pancewicz S; Zajkowska J; Dunaj J; Kondrusik M; Krawczuk K; Moniuszko-Malinowska A
Postepy Hig Med Dosw (Online); 2017 Jan; 71(1):788-796. PubMed ID: 28894041
[TBL] [Abstract][Full Text] [Related]
27. DC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infection.
Kashima S; Rodrigues ES; Azevedo R; da Cruz Castelli E; Mendes-Junior CT; Yoshioka FKN; da Silva IT; Takayanagui OM; Covas DT
J Gen Virol; 2009 Apr; 90(Pt 4):927-934. PubMed ID: 19264667
[TBL] [Abstract][Full Text] [Related]
28. CD209 in inflammatory bowel disease: a case-control study in the Spanish population.
Núñez C; Oliver J; Mendoza JL; Gómez-García M; Taxonera C; Gómez LM; López-Nevot MA; de la Concha EG; Urcelay E; Martínez A; Martín J
BMC Med Genet; 2007 Dec; 8():75. PubMed ID: 18070336
[TBL] [Abstract][Full Text] [Related]
29. CD209 genetic polymorphism and tuberculosis disease.
Vannberg FO; Chapman SJ; Khor CC; Tosh K; Floyd S; Jackson-Sillah D; Crampin A; Sichali L; Bah B; Gustafson P; Aaby P; McAdam KP; Bah-Sow O; Lienhardt C; Sirugo G; Fine P; Hill AV
PLoS One; 2008 Jan; 3(1):e1388. PubMed ID: 18167547
[TBL] [Abstract][Full Text] [Related]
30. A novel CD209 polymorphism is associated with rheumatoid arthritis patients in Taiwan.
Chan HC; Wang SC; Lin CH; Lin YZ; Li RN; Yen JH
J Clin Lab Anal; 2021 May; 35(5):e23751. PubMed ID: 33792986
[TBL] [Abstract][Full Text] [Related]
31. Contrasting associations of polymorphisms in FcγRIIa and DC-SIGN with the clinical presentation of dengue infection in a Mexican population.
Noecker CA; Amaya-Larios IY; Galeana-Hernández M; Ramos-Castañeda J; Martínez-Vega RA
Acta Trop; 2014 Oct; 138():15-22. PubMed ID: 24911936
[TBL] [Abstract][Full Text] [Related]
32. [Polymorphism of CD209 and TLR3 genes in populations of North Eurasia].
Barkhash AV; Babenko VN; Voevoda MI; Romaschenko AG
Genetika; 2016 Jun; 52(6):697-704. PubMed ID: 29368829
[TBL] [Abstract][Full Text] [Related]
33. Association of single nucleotide polymorphisms in the CD209, MMP9, TNFA and IFNG genes with susceptibility to Japanese encephalitis in children from North India.
Deval H; Alagarasu K; Srivastava N; Bachal R; Mittal M; Agrawal A; Bote M; Gondhalekar A; Bondre VP; Kant R
Gene; 2022 Jan; 808():145962. PubMed ID: 34530082
[TBL] [Abstract][Full Text] [Related]
34. Association of the OAS3 rs1859330 G/A genetic polymorphism with severity of enterovirus-71 infection in Chinese Han children.
Tan Y; Yang T; Liu P; Chen L; Tian Q; Guo Y; He H; Liu Y; Chen Z
Arch Virol; 2017 Aug; 162(8):2305-2313. PubMed ID: 28444539
[TBL] [Abstract][Full Text] [Related]
35. Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis.
Zhao Y; Kang H; Ji Y; Chen X
Clin Exp Med; 2013 Aug; 13(3):171-6. PubMed ID: 22710942
[TBL] [Abstract][Full Text] [Related]
36. Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients.
Ben-Ali M; Barreiro LB; Chabbou A; Haltiti R; Braham E; Neyrolles O; Dellagi K; Gicquel B; Quintana-Murci L; Barbouche MR
Hum Immunol; 2007 Nov; 68(11):908-12. PubMed ID: 18082570
[TBL] [Abstract][Full Text] [Related]
37. Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
Tessier MC; Qu HQ; Fréchette R; Bacot F; Grabs R; Taback SP; Lawson ML; Kirsch SE; Hudson TJ; Polychronakos C
J Med Genet; 2006 Feb; 43(2):129-32. PubMed ID: 16014697
[TBL] [Abstract][Full Text] [Related]
38. Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis.
Gómez LM; Anaya JM; Sierra-Filardi E; Cadena J; Corbí A; Martín J
Hum Immunol; 2006 Oct; 67(10):808-11. PubMed ID: 17055357
[TBL] [Abstract][Full Text] [Related]
39. Common haplotypes in CD209 promoter and susceptibility to HIV-1 infection in intravenous drug users.
Herrero R; Pineda JA; Rivero-Juarez A; Echbarthi M; Real LM; Camacho A; Macias J; Fibla J; Rivero A; Caruz A
Infect Genet Evol; 2016 Nov; 45():20-25. PubMed ID: 27539513
[TBL] [Abstract][Full Text] [Related]
40. Association of Single-Nucleotide Polymorphisms in DC-SIGN with Nasopharyngeal Carcinoma Susceptibility.
Li S; Lu Z; Yao M; Ning S; Wu Y; Zhou X; Zhong C; Yan K; Xie Y; Wei Z
Dis Markers; 2017; 2017():6309754. PubMed ID: 28694559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
